CURRENT TRENDS IN DEVELOPMENT AND PRODUCTION OF NANOSCALE DRUG DELIVERY SYSTEMS by Elena V. Popova, Petr P. Beltyukov, Andrey S. Radilov

“…Currently, most of the largest pharmaceutical companies are developing delivery systems, both for new drugs and for already existing ones. …”
Get full text

Outreach Efforts to Prevent Newcastle Disease Outbreaks in Southern California by Alejandra Figueroa, Esteban Escobedo, Marco Solis, Charlene Rivera, Ann Ikelman, Rodrigo A. Gallardo

“…Additionally, with the help of the CDFA, the USDA, and pharmaceutical companies, Newcastle disease vaccines and training for their application were provided to feedstores with gamefowl breeder clientele. …”
Get full text

The medical science liaison role in Spain: A nationwide survey by Víctor Sastre, Adela Matesanz-Marín, Cristina García, Antonio González del Castillo

“…The survey was open to current MSLs from different pharmaceutical companies in Spain and included questions about the participant profile, activity development, performance evaluation, and career development. …”
Get full text

Pharmaceutical policies and regulations of oral antiviral drugs for treatment of hepatitis C in Egypt—case study by Mahmoud H. Teaima, Adi Al-Nuseirat, Dalia Abouhussein, Osama A. Badary, Mohamed A. El-Nabarawi

“…In addition, political will and collaboration between the government, civil society, and pharmaceutical companies improved patients’ access to affordable DAAs and succeeding hepatitis C treatment in Egypt. …”
Get full text

The distributed ledger technology as a measure to minimize risks of poor-quality pharmaceuticals circulation by Aleksandr Erokhin, Konstantin Koshechkin, Ilya Ryabkov

“…The analysis of present-day pharmaceuticals supply chain structure and the distributed ledger technology capacities to improve pharmaceutical companies has been carried out and presented. …”
Get full text

Hydrocephalus: historical analysis and considerations for treatment by Alexandra Hochstetler, Jeffrey Raskin, Bonnie L. Blazer-Yost

“…The development of new treatment paradigms relies heavily on investment in researching the common molecular mechanisms that contribute to all of the forms of hydrocephalus, and requires the concerted support of patient advocacy organizations, government- and private-funded research, biotechnology and pharmaceutical companies, the medical device industry, and the vast network of healthcare professionals.…”
Get full text

Market mapping and landscape analysis of human rabies biologicals in India by Mysore Kalappa Sudarshan, Doddabele Hanumanthaiah Ashwath Narayana, Mahendra Bangalore Jayakrishnappa

“…Results: Two types of cell culture rabies vaccines are available in the country manufactured by different pharmaceutical companies; most of the vaccines are indigenously produced and the market size of the rabies vaccines is about INR 125 crores with highest sales in the northern region followed by South. …”
Get full text

Reimbursement Lag of New Drugs Under Taiwan's National Health Insurance System Compared With United Kingdom, Canada, Australia, Japan, and South Korea by Yi‐Ru Shih, Kai‐Hsin Liao, Yen‐Hui Chen, Fang‐Ju Lin, Fei‐Yuan Hsiao

“…For other drug classes, the reimbursement price proposed by pharmaceutical companies and use of price‐volume agreements were two statistically significant parameters associated with longer reimbursement lags. …”
Get full text

Characteristics of Clinical Trials in Iran: A Sample of 5000 Trials Registered in Iranian Registry of Clinical Trials (IRCT) by F Fakhri, S Eybpoosh, M Solaymani Dodaran

“…Only 1% of the trials were exclusively sponsored by pharmaceutical companies.   Conclusion: The majority of clinical trials conducted in Iran are investigator-initiated and are funded by the public sector. …”
Get full text

Managing severe pain and abuse potential: the potential impact of a new abuse-deterrent formulation oxycodone/naltrexone extended-release product by Pergolizzi, J, Pergolizzi, Jr JV, Taylor Jr R, LeQuang JA, Raffa RB

“…In an effort to provide efficacious strong pain relievers (opioids) that are more difficult to abuse by the most dangerous routes of administration, pharmaceutical companies are developing products in which the opioid is manufactured in a formulation that is designed to be tamper resistant. …”
Get full text

Calculation, knowledge, and identity: Dimensions of trust when making COVID-19 vaccination choices in China by Lirui Jiao, Jonas Wachinger, Selina Dasch, Till Bärnighausen, Shannon A. McMahon, Simiao Chen

“…Reducing negative impact from past vaccine controversies, increasing the credibility of pharmaceutical companies, and fostering clear communication are identified as important channels for facilitating trust. …”
Get full text

Disease progression joint model predicts time to type 1 diabetes onset: Optimizing future type 1 diabetes prevention studies by Juan Francisco Morales, Rhoda Muse, Jagdeep T. Podichetty, Jackson Burton, Sarah David, Patrick Lang, Stephan Schmidt, Klaus Romero, Inish O'Doherty, Frank Martin, Martha Campbell‐Thompson, Michael J. Haller, Mark A. Atkinson, Sarah Kim

“…This model provides a framework to quantitatively predict and simulate the time to type 1 diabetes diagnosis in individuals at risk of developing the disease and thus, aligns with the needs of pharmaceutical companies and scientists seeking to advance therapies aimed at interdicting the disease process.…”
Get full text

Sharing of Clinical Trial Data and Samples: The Cancer Patient Perspective by Stefanie Broes, Stefanie Broes, Ciska Verbaanderd, Ciska Verbaanderd, Minne Casteels, Denis Lacombe, Isabelle Huys

“…Journal editors, pharmaceutical companies, funding agencies, governmental organizations, regulators, and clinical investigators have been debating the legal, ethical, and social implications of clinical data and sample sharing for several years. …”
Get full text

ENFORCEMENT STATUS OF THE POISON ACT 1952 AGAINST OFFENCES RELATED TO KRATOM (MITRAGYNA SPECIOSA KORTH) MISUSE IN MALAYSIA by Samihah Khalil@Halim, Rusniah Ahmad, Siti Alida John Abdullah

“…In pharmacology, there is research and development demand for kratom, and demands from international pharmaceutical companies for kratom had created illegal rational economic exploitation of Malaysia’s kratom by individuals, so to speak resulting in more intricacies to existing complication. …”
Get full text

<i>Ganoderma lucidum</i> Ethanol Extracts Enhance Re-Epithelialization and Prevent Keratinocytes from Free-Radical Injury by Mario Abate, Giacomo Pepe, Rosario Randino, Simona Pisanti, Manuela Giovanna Basilicata, Verdiana Covelli, Maurizio Bifulco, Walter Cabri, Anna Maria D’Ursi, Pietro Campiglia, Manuela Rodriquez

“…Moreover, lately, there has been an increasing interest from pharmaceutical companies in antiaging <i>G. lucidum</i>-extract-based formulations. …”
Get full text

Antimicrobial properties of medicinal plants; The new therapeutic aspect of Valeriana officinalis by Zohre Eftekhari

“…The outbreak of the world's emerging and re-emerging infectious diseases has prompted pharmaceutical companies to develop new medicines. Valerian is one of the worldwide recognized medicinal herbs that consume abundantly for the treatment of various human diseases and disorders. …”
Get full text

Hypertrophic cardiomyopathy: Mutations to mechanisms to therapies by Masataka Kawana, Masataka Kawana, James A. Spudich, Kathleen M. Ruppel

“…Recently, two pharmaceutical companies have developed small molecule inhibitors of human cardiac myosin to counteract the molecular consequences of HCM pathogenesis. …”
Get full text

Organisation of the Russian Pharmacovigilance System: Survey of Pharmacovigilance Officers by A. E. Krasheninnikov, A. V. Matveev, S. D. Marchenko

“…Survey of qualified pharmacovigilance experts on current problems in pharmacovigilance is one of the tools for improving the pharmacovigilance system efficiency.The aim of the study was to analyse the Russian pharmacovigilance system organisation based on the results of a survey of pharmacovigilance officers.Materials and methods: the authors carried out a survey of 26 pharmacovigilance officers from pharmaceutical companies.Results: the majority of the respondents (50%) had short work experience in this area and combined pharmacovigilance duties with other functions in the company. …”
Get full text

Internet Hospitals in China - Exploration of Business Models and Marketing Strategies by Yang, Xi

“…The profitable multi-win business model proposed in this paper is to charge patients, medical students and young doctors, pharmaceutical companies, insurance companies, and medical device companies. …”
Get full text

Assessing the challenge of policing animal rights extremism in the UK and the changing impact on community safety and human rights in the period 2004-2010 by Mills, Gordon Roy

“…It argues that following the successful targeting of major pharmaceutical companies leading up to 2004, by animal rights campaigners deploying a variety of effective tactics based primarily on intimidation and harassment - the government, the police and the targeted industries, robustly responded in a coordinated strategic approach to reduce animal rights crimes. …”
Get full text